By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Agennix AG 

Munich      Germany
Phone: n/a Fax: n/a



Company News
Agennix AG (GAGXF) Schedules Fiscal Year 2012 Reporting Date and Conference Call on March 28 2/19/2013 9:08:24 AM
Agennix AG (GAGXF) Axes 55 Percent of Jobs as Part of Restructuring 8/24/2012 7:24:46 AM
Agennix AG Reports Results of FORTIS-M Phase III Trial With Talactoferrin Alfa in Non-Small Cell Lung Cancer 8/7/2012 9:47:53 AM
Agennix AG Reports Financial Results for Second Quarter and First Half of 2012 7/31/2012 9:16:30 AM
Agennix AG Announces Notice of Allowance for U.S. Patent Application Covering Use of Talactoferrin Alfa to Treat Non-Small Cell Lung Cancer and Renal Cancer in Combination With Other Treatments 7/30/2012 9:14:57 AM
Agennix AG Schedules Conference Call on July 31 to Discuss Second Quarter 2012 Financial Results 7/25/2012 9:10:17 AM
Agennix AG Reports Financial Results for First Quarter of 2012 5/9/2012 11:36:58 AM
Agennix AG to Present at BioEquity Europe 2012 on May 15 5/4/2012 9:30:27 AM
Agennix AG Schedules Conference Call on May 9 to Discuss First Quarter 2012 Financial Results 5/2/2012 8:22:35 AM
Lonza Inc. and Agennix AG Sign Development and Manufacturing Deal for Production of Talactoferrin 4/12/2012 9:23:17 AM